Journal of Cardiovascular Development and Disease (May 2022)

A Systematic Review of Adherence to Immunosuppression among Pediatric Heart Transplant Patients

  • Keira Nassetta,
  • Tasmeen Hussain,
  • Katheryn Gambetta,
  • Kevin Le,
  • Linda C. O’Dwyer,
  • Sherif M. Badawy

DOI
https://doi.org/10.3390/jcdd9050165
Journal volume & issue
Vol. 9, no. 5
p. 165

Abstract

Read online

After pediatric heart transplant, commitment to lifelong immunosuppression is crucial to maintaining graft health. However, a review of the current literature surrounding adherence to immunosuppression in pediatric heart transplant patients is lacking. This systematic review aims to summarize the current landscape of adherence to immunosuppression in pediatric heart transplant patients. We conducted searches in PubMed MEDLINE, Embase, CENTRAL register of Controlled Trials (Wiley), and Scopus, from inception to March 2020. Studies were eligible if they outlined an aspect of adherence to immunosuppression and the measurement of adherence was performed with an objective or otherwise validated measure of adherence (e.g., drug levels, adherence questionnaires). The titles/abstracts of 880 articles were reviewed. After initial screening, 106 articles underwent full text review. As such, 14 articles were included in the final review. Baseline adherence estimates varied greatly, with most values between 40% and 70%. Nonadherence to immunosuppression is associated with worse outcomes (rejection, hospitalization, mortality), impaired quality of life, and mental health concerns in pediatric heart transplant patients. As nonadherence to immunosuppression is common and associated with worse outcomes, there is a need for further development and evaluation of interventions in this space.

Keywords